Fig. 2
From: Managing adherence, exposure, and toxicity in oral anticancer therapies
Factors reducing adherence to trifluridine/tipiracil hydrochloride treatment (85 instances)
Fig. 2 | Journal of Pharmaceutical Health Care and Sciences